Goldman Sachs Physical Gold ETF vs AstraZeneca plc — how do they compare? Goldman Sachs Physical Gold ETF trades at $43.44, while AstraZeneca plc trades at $158.4 (market cap $248.14B). The key difference: AstraZeneca plc pays a 2.01% dividend while Goldman Sachs Physical Gold ETF pays none, and Goldman Sachs Physical Gold ETF is trading nearer its 52-week high, AstraZeneca plc nearer its low. Which is the better fit depends on your goals.
| AAAU | AZN | |
|---|---|---|
Sector | Commodities - Metals/Agriculture | Health |
52-Week High | $53.21 | $209.48 |
52-Week Low | $32.74 | $147.06 |
Market Cap | — | $248.14B |
Enterprise Value | — | $275.41B |
Dividend Yield | — | 2.01% |
Signals from Pluang's Aura AI — not financial advice
AAAU, a US-listed gold-focused asset, trades at $43.52, up 0.58% on the day, with a bullish technical signal from moving averages but overbought RSI readings. Recent news highlights gold's strength amid cooling US inflation and geopolitical tensions, with spot gold hitting $4,438/oz. The stock lacks disclosed financial ratios, indicating potential data gaps for fundamental analysis.
The outlook for AAAU is tied to gold's momentum, supported by Fed policy expectations and safe-haven demand, but risks include volatility from economic data and overbought conditions. Investors should weigh gold's bullish trends against the absence of company-specific fundamentals and high RSI levels suggesting near-term caution.
AstraZeneca (AZN) trades at $158.48, down 2.12% amid bearish technical signals and merger speculation. The stock shows strong fundamentals with revenue growth from $54.1B in 2024 to $58.7B in 2025 and net income reaching $10.2B. Recent earnings beats and a 47.5% analyst buy rating contrast with technical indicators showing oversold conditions near key support at $155.
Investment outlook remains positive based on earnings momentum and valuation metrics (P/E 23.76), though risks include potential merger integration challenges and ongoing legal investigations. The company's robust cash flow generation and dividend payments provide shareholder value support despite near-term volatility.
Trailing returns across standard periods
Latest headlines on both assets
AAAU tracks the price of gold bullion by holding physical gold bars in secure vaults. Managed by Goldman Sachs, this ETF offers a cost-effective way to gain direct exposure to gold without the logistical challenges of storage or insurance.
Read more on AAAU →A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, and immunology. The majority of sales come from international markets with the United States representing close to one third of its sales.
Read more on AZN →